Top-News
Biotechnologie USA

Geron Corp Aktie

Aktie
WKN:  902213 ISIN:  US3741631036 US-Symbol:  GERN
3,526 €
+0,022 €
+0,63%
03.01.25
Handeln Depot/Watchlist
Aktienanzahl *
593,13 Mio.
Marktkapitalisierung *
2,23 Mrd. €
Streubesitz
14,53%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 26.06.2024

Geron Corp News

07.03.24 - PR Newswire
Thinking about buying stock in Onespan, Avinger, Lithium Americas, Geron, or Femasys?
Thinking about buying stock in Onespan, Avinger, Lithium Americas, Geron, or Femasys? PR Newswire
05.03.24 - PR Newswire
Thinking about buying stock in Ocean Biomedical, CASI Pharmaceuticals, Cardiol Therapeutics, Geron, or Rocket Pharmaceuticals?
Thinking about buying stock in Ocean Biomedical, CASI Pharmaceuticals, Cardiol Therapeutics, Geron, or Rocket Pharmaceuticals? PR Newswire
01.03.24 - PR Newswire
Thinking about buying stock in Minim, GameSquare, Laser Photonics, Geron, or Mind Medicine?
Thinking about buying stock in Minim, GameSquare, Laser Photonics, Geron, or Mind Medicine? PR Newswire
03.09.23 - Gurupress
Geron Aktie weiter unter Druck: Schwierige Zeiten oder Kaufchance?
Das bedeutet, dass die Geron Aktie weiterhin unter Verkaufsdruck steht und sich in einem Abwärtstrend befindet. Die nächsten wichtigen Unterstützungen liegen bei 3,50 EUR und ...
05.06.23 - PR Newswire
Thinking about buying stock in SoFi Technologies, ImmunoGen, Equitrans Midstream, Geron, or Microvision?
Thinking about buying stock in SoFi Technologies, ImmunoGen, Equitrans Midstream, Geron, or Microvision? PR Newswire
31.05.23 - PR Newswire
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June PR Newswire
31.05.23 - PR Newswire
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June PR Newswire
06.01.23 - PR Newswire
Thinking about buying stock in Zomedica, Nio, Geron Corp, Microsoft, or Lucid Group?
Thinking about buying stock in Zomedica, Nio, Geron Corp, Microsoft, or Lucid Group? PR Newswire
04.01.23 - PR Newswire
Thinking about buying stock in Geron Corp, InMed Pharmaceuticals, Kingsoft Cloud, Vivos Therapeutics, or Baozun?
Thinking about buying stock in Geron Corp, InMed Pharmaceuticals, Kingsoft Cloud, Vivos Therapeutics, or Baozun? PR Newswire
06.06.22 - PR Newswire
Lead Plaintiffs and Class Representatives Julia Junge and Richard Junge Announce Summary Notice of Pendency of Class Action (Nasdaq: GERN)
Lead Plaintiffs and Class Representatives Julia Junge and Richard Junge Announce Summary Notice of Pendency of Class Action (Nasdaq: GERN) PR Newswire
22.06.21 - PR Newswire
Thinking about buying stock in ContextLogic, Adial Pharmaceuticals, Geron Corp, Orphazyme, or Citius Pharmaceuticals?
Thinking about buying stock in ContextLogic, Adial Pharmaceuticals, Geron Corp, Orphazyme, or Citius Pharmaceuticals? PR Newswire
21.06.21 - PR Newswire
Thinking about buying stock in Geron Corp, Ashford Hospitality Trust, Paratek Pharmaceuticals, Seanergy Maritime, or TAL Education?
Thinking about buying stock in Geron Corp, Ashford Hospitality Trust, Paratek Pharmaceuticals, Seanergy Maritime, or TAL Education? PR Newswire
18.06.21 - PR Newswire
Thinking about buying stock in Geron Corp, Vaxart, Orphazyme, Athira Pharma, or TAL Education?
Thinking about buying stock in Geron Corp, Vaxart, Orphazyme, Athira Pharma, or TAL Education? PR Newswire
19.04.21 - PR Newswire
SHAREHOLDER ALERT: Geron Corporation (GERN) Officers and Directors Under Investigation for False Statements and Insider Trading
SHAREHOLDER ALERT: Geron Corporation (GERN) Officers and Directors Under Investigation for False Statements and Insider Trading PR Newswire
20.02.20 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Geron Corporation of Class Action Lawsuit and Upcoming Deadline - GERN
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Geron Corporation of Class Action Lawsuit and Upcoming Deadline - ...
14.02.20 - PR Newswire
GERN Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against Geron Corporation (NASDAQ: GERN); Lead Plaintiff Deadline is March 23, 2020
GERN Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against Geron Corporation (NASDAQ: GERN); Lead Plaintiff Deadline is March 23, 2020 PR ...
11.02.20 - Newsfile
Geron Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Geron Corporation To Contact The Firm
New York, New York--(Newsfile Corp. - February 11, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Geron Corporation (NASDAQ: GERN) ...
07.02.20 - Newsfile
GERON SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Geron Corporation To Contact The Firm
New York, New York--(Newsfile Corp. - February 7, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Geron Corporation (NASDAQ: GERN) ...
04.02.20 - Newsfile
GERON DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Geron Corporation To Contact The Firm
New York, New York--(Newsfile Corp. - February 4, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Geron Corporation (NASDAQ: GERN) ...
31.01.20 - PR Newswire
GERON CORPORATION INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action has been filed in the United States District Court for the Northern District of California on behalf of investors in Geron Corporation
GERON CORPORATION INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action has been filed in the United States District Court ...

Newssuche

Videos

newspaper
05.01.25
Strategien mit 500-2000% Performance
Gerade als Trader mit begrenzter Kapitaldecke benötigt man Strategien, die relativ wenig Kapital binden ... Mehr »